ASCO Action Center
Immerse yourself in the latest oncological breakthroughs with the ASCO Action Center, which offers an in-depth look at the research and clinical advancements unveiled at the American Society of Clinical Oncology (ASCO) Annual Meeting and even its affiliated conferences like the Genitourinary Cancers (ASCO-GU) Symposium. Gain exclusive access to the expert analyses, dynamic discussions, and cutting-edge treatment strategies presented at the conference that are redefining cancer care.
Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Project Oncology®Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Project Oncology®Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Project Oncology®One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Project Oncology®Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Project Oncology®Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Project Oncology®Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
- advertisement
society.asco.org
06/07/2024
society.asco.org
06/06/2024
newswise.com
06/05/2024
society.asco.org
06/05/2024
uclahealth.org
05/28/2024
clinicaltrialsarena.com
05/20/2024



























